Monopar Therapeutics MNPR Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Monopar Therapeutics’s reported figures.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's enterprise value?
- Monopar Therapeutics (MNPR) reported enterprise value of $314.35M in Q1 2026.
- How has Monopar Therapeutics's enterprise value changed year-over-year?
- Monopar Therapeutics's enterprise value increased by 72.3% year-over-year, from $182.49M to $314.35M.
- What is the long-term trend for Monopar Therapeutics's enterprise value?
- Over 2 years (2022 to 2025), Monopar Therapeutics's enterprise value has grown at a 308.2% compound annual growth rate (CAGR), from $22.49M to $374.78M.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.